Pregnancy-Related and Perinatal Outcomes in Women With Multiple SclerosisJohanna Balslev Andersen, Melinda Magyari, Tine Iskov Kopp et al.|Neurology Clinical Practice|2021Cited by 28
Pregnancy Outcomes in Men and Women Treated With Teriflunomide. A Population-Based Nationwide Danish Register StudyJohanna Balslev Andersen, Melinda Magyari, Julie Yoon Moberg et al.|Frontiers in Immunology|2018Cited by 24
Pregnancy outcomes following maternal or paternal exposure to teriflunomide in the Danish MS populationJohanna Balslev Andersen, Melinda Magyari, Malthe Faurschou Wandall‐Holm|Multiple Sclerosis and Related Disorders|2022Cited by 22
Pregnancy outcomes after early fetal exposure to injectable first‐line treatments, dimethyl fumarate, or natalizumab in Danish women with multiple sclerosisJohanna Balslev Andersen, Melinda Magyari, Finn Sellebjerg|European Journal of Neurology|2022Cited by 19
The effectiveness of natalizumab vs fingolimod–A comparison of international registry studiesJohanna Balslev Andersen, Gilles Edan, Sifat Sharmin et al.|Multiple Sclerosis and Related Disorders|2021Cited by 12